{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:5234",
      "entity_text" : "salt",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:182137",
      "entity_text" : "esketamine",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The esketamine concentration was slightly increased from 0.81 to 0.87 mg/mL to achieve precisely a 1-mg/mL concentration in hydrochloride salt, the study drug was provided in prefilled syringes instead of vials, and the 3 doses could be administered over 3 to 5 days instead of 3 straight days to allow for more scheduling flexibility.",
  "reading_complete" : "2020-08-04T09:07:44Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T09:05:51Z",
  "trigger" : "increased",
  "evidence" : [ "esketamine concentration was slightly increased from 0.81 to 0.87 mg/mL to achieve precisely a 1-mg/mL concentration in hydrochloride salt" ],
  "pmc_id" : "5673013",
  "score" : 0
}